A New Form of Fentanyl
Federal Practitioner. 2009 November;26(11):E3
November 1, 2009|Federal Practitioner
Author and Disclosure Information
In July, the FDA approved fentanyl buccal soluble film (FBSF) (Onsolis, Aveva Drug Delivery Systems, Miramar, FL), a new form of the opioid fentanyl. FBSF is indicated to treat breakthrough cancer pain in patients who already are receiving and have become tolerant to opioids. The drug is delivered through a film that sticks to the inside of the cheek and dissolves within 15 to 30 minutes.
